Journal Article

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy

Li, Xiaochen, Bergerot, Cristiane D., Tripathi, Abhishek, Staehler, Michael D., Zengin, Zeynep B., Mercier, Benjamin, Castro, Daniela, Chawla, Neal, Salgia, Nicholas J., Dizman, Nazli, Battle, Dena, Barragan-Carrillo, Regina, Ebrahimi, Hedyeh, Liu, Sandy T., Vaishampayan, Ulka, Meza, Luis, Pal, Sumanta K., Hsu, JoAnn, Chehrazi-Raffle, Alex

2024

Overview

Many patients diagnosed with cancer adopt dietary changes and supplement use, and a growing body of evidence suggests that such modifications can affect outcomes to cancer therapy. We sought to assess the prevalence of these practices and the surrounding physician-patient dialogue among patients with metastatic renal cell carcinoma. An online survey was administered by Kidney Cancer Research Alliance (KCCure), interrogating dietary modification patterns, supplement usage, out-of-pocket expenditure related to supplements, and patients’ views toward alternative medicine practices. Patients with metastatic renal cell carcinoma receiving combination therapy were actively solicited. In total, 289 unique responses were collected. The most common first-line treatments were nivolumab/ipilimumab (32.4%) and axitinib/pembrolizumab (13.1%). Within the cohort, 147 (50.9%) started using supplements following diagnosis of renal cell carcinoma; the most utilized supplements were probiotics, cannabidiol (CBD) oil/marijuana, and Vitamin C, reported by 70 (47.6%), 61 (41.4%), and 54 (36.7%), respectively. Dietary modifications following cancer diagnosis were reported by 101 (34.9%) respondents, of which 19.8% followed the Mediterranean diet and 18.8% adopted a ketogenic diet. Most respondents (71.3%) noted that they consistently report supplement usage to their physicians. A substantial proportion of patients with metastatic renal cell carcinoma utilize dietary modification and supplements as an adjunct to antineoplastic therapy. Considering the widespread adoption of these practices and the reported effects on cancer treatment, it is crucial for healthcare providers to engage in discussions with patients regarding supplement use.

• Publisher: MDPI AG,MDPI
• Subject: Adult / Aged / Alternative medicine / Cancer therapies / Carcinoma, Renal cell / Carcinoma, Renal Cell - epidemiology / Carcinoma, Renal Cell - therapy / Diet / Diet therapy / Diet, Mediterranean - statistics & numerical data / Dietary Supplements / Drug therapy / Female / Humans / Information sharing / Kidney cancer / Kidney Neoplasms / Male / Medical diagnosis / Medical prognosis / Medical research / Metastasis / Middle Aged / Monoclonal antibodies / Mortality / Neoplasm Metastasis / Nutrition research / Patients / Polls & surveys / Prevalence / Probiotics / Social networks / Statistics / Surveys and Questionnaires / User statistics / Vascular endothelial growth factor